GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (LIM:BMY) » Definitions » Total Liabilities

Bristol-Myers Squibb Co (LIM:BMY) Total Liabilities : $76,215 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Bristol-Myers Squibb Co Total Liabilities?

Bristol-Myers Squibb Co's Total Liabilities for the quarter that ended in Dec. 2024 was $76,215 Mil.

Bristol-Myers Squibb Co's quarterly Total Liabilities declined from Jun. 2024 ($77,577.00 Mil) to Sep. 2024 ($76,470.00 Mil) and declined from Sep. 2024 ($76,470.00 Mil) to Dec. 2024 ($76,215.00 Mil).

Bristol-Myers Squibb Co's annual Total Liabilities declined from Dec. 2022 ($65,702.00 Mil) to Dec. 2023 ($65,674.00 Mil) but then increased from Dec. 2023 ($65,674.00 Mil) to Dec. 2024 ($76,215.00 Mil).


Bristol-Myers Squibb Co Total Liabilities Historical Data

The historical data trend for Bristol-Myers Squibb Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Total Liabilities Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 80,599.00 73,308.00 65,702.00 65,674.00 76,215.00

Bristol-Myers Squibb Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65,674.00 82,483.00 77,577.00 76,470.00 76,215.00

Bristol-Myers Squibb Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Bristol-Myers Squibb Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=23774+(48973+522
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+1055+400+1491)
=76,215

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=92603-16388
=76,215

Bristol-Myers Squibb Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=23774+(48973+522
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+1055+400+1491)
=76,215

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=92603-16388
=76,215

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bristol-Myers Squibb Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co Business Description

Address
Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.